PHAT
#2691
Phathom Pharmaceuticals, Inc. - Common Stock
8.9 4 USD
+0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.94%
Monthly Change
-25.00%
6 month change
-26.30%
Year Change
-28.25%
Previous Close
8.7 7
Open
8.9 4
Low
8.9 4
High
8.9 4
Volume
85
Financials
- Market Capitalization 723.25 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.48
Price to sales ratio
6.91
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2674 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.68 USD | +0.45% | -5.65% | +13.03% | -19.13% | 744.89 M USD | ||
| 2683 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.18 USD | -0.86% | -0.11% | +6.25% | -4.87% | 736.00 M USD | ||
| 2692 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.09 USD | +2.45% | -1.42% | +20.11% | +77.12% | 722.08 M USD | ||
| 2699 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.70 USD | +2.03% | +0.77% | +23.03% | +113.99% | 717.46 M USD |
Frequently asked questions about Phathom Pharmaceuticals, Inc. Common Stock
What is the Phathom Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Phathom Pharmaceuticals, Inc. Common Stock (PHAT) is 8.94. Over the past 24 hours, the stock has changed by +1.94%. Follow the PHAT chart for real-time price dynamics.
What is the stock ticker of Phathom Pharmaceuticals, Inc. Common Stock?
Phathom Pharmaceuticals, Inc. Common Stock trades under the ticker PHAT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Phathom Pharmaceuticals, Inc. Common Stock stock going up?
PHAT has changed by +3.59% over the last week, -25.00% over the last month, and -28.25% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Phathom Pharmaceuticals, Inc. Common Stock?
Phathom Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 723.25 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Phathom Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Phathom Pharmaceuticals, Inc. Common Stock reported earnings of -0.21 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Phathom Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Phathom Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 74.27 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Phathom Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Phathom Pharmaceuticals, Inc. Common Stock reported net income of -17.58 M for the last quarter. The previous quarter showed -30.37 M, which means net income changed by +42.11%.
How many employees does Phathom Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Phathom Pharmaceuticals, Inc. Common Stock has 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is Phathom Pharmaceuticals, Inc. Common Stock EBITDA?
Phathom Pharmaceuticals, Inc. Common Stock EBITDA is -3.85 M, and its EBITDA margin is -5.18%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Phathom Pharmaceuticals, Inc. Common Stock stock?
You can buy Phathom Pharmaceuticals, Inc. Common Stock (PHAT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Phathom Pharmaceuticals, Inc. Common Stock stock?
Investing in Phathom Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PHAT chart and related analysis on metatrader.com as part of your research.